advances in intratumoral therapy and an update on the bdb001-102 trial
Published 2 years ago • 142 plays • Length 6:12Download video MP4
Download video MP3
Similar videos
-
1:44
intratumoral immunotherapy with bo-112 pembrolizumab in patients with anti-pd1 refractory melanoma
-
2:44
advances in perioperative immunotherapy in lung cancer
-
1:30
horizon scanning in interventional pulmonology: intratumoral therapy & tumor ablation
-
3:28
advances in immune regulation and tumor immunotherapy
-
2:35
intratumoral immunotherapy for cancer.
-
5:57
intratumoral immunotherapy | dr. jason williams
-
0:51
intratumoral immunotherapy plus chemotherapy
-
5:15
efficacy and safety of medi1191 in patients with solid tumors and superficial lesions
-
58:19
artificial intelligence-based biomarkers in precision oncology | jakob nikolas kather
-
3:03
apa itu imunoterapi? - dr. shum weng yoon - mahkota medical centre
-
30:53
immunotherapy side effects: what patients need to know with dr. jeffery weber
-
2:03
antibiotics impact outcomes with pembrolizumab in nsclc patients
-
1:58
who benefits from immunotherapy in patients with advanced escc?
-
54:57
immunotherapy advances in treatment
-
6:26
selecting patients for immunotherapy based on driver mutations
-
3:40
cancer procedure: intratumoral injection of combination immunotherapy into the liver mass with sbrt
-
5:21
immunotherapy for brain tumors
-
6:01
the evolution of immunotherapy in brain tumor treatment
-
1:29
cmp-001 for melanoma and hnscc
-
1:06
immunotherapy for cancer - dr. amar raval
-
2:35
intratumoral immunotherapy plus chemotherapy
-
0:50
phase i study of tak-676 pembrolizumab following radiotherapy in late-line nsclc, tnbc and scchn